ME Therapeutics Holdings Inc. (CSE:METX)
Canada · Delayed Price · Currency is CAD 3.040
+0.040 (1.33%)
Jul 21, 2026, 12:59 PM EST
ME Therapeutics Holdings Market Cap
ME Therapeutics Holdings has a market cap or net worth of CAD 90.15 million as of July 21, 2026. Its market cap has decreased by -39.07% in one year.
Market Cap
90.15M
Enterprise Value
89.64M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.04
ChartMarket Cap Chart
Since October 12, 2023, ME Therapeutics Holdings's market cap has increased from 14.43M to 90.15M, an increase of 524.68%. That is a compound annual growth rate of 93.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 90.15M | -25.00% |
| Dec 17, 2025 | 120.20M | 19.29% |
| Dec 30, 2024 | 100.76M | 256.37% |
| Dec 29, 2023 | 28.27M | 95.92% |
| Oct 12, 2023 | 14.43M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Helix BioPharma | 106.93M |
| Eastwood Bio-Medical Canada | 66.82M |
| NurExone Biologic | 47.46M |
| BriaCell Therapeutics | 45.76M |
| MedMira | 45.61M |
| Sernova Biotherapeutics | 41.54M |
| Microbix Biosystems | 41.33M |
| Onco-Innovations | 38.72M |